Login / Signup

Design, Synthesis, and Evaluation of N- and C-Terminal Protein Bioconjugates as G Protein-Coupled Receptor Agonists.

Robert D HealeyJonathan P WojciechowskiAna Monserrat-MartinezSusan L TanChristopher P MarquisEmma SiereckiYann GambinAngela M FinchPall Thordarson
Published in: Bioconjugate chemistry (2018)
A G protein-coupled receptor (GPCR) agonist protein, thaumatin, was site-specifically conjugated at the N- or C-terminus with a fluorophore for visualization of GPCR:agonist interactions. The N-terminus was specifically conjugated using a synthetic 2-pyridinecarboxyaldehyde reagent. The interaction profiles observed for N- and C-terminal conjugates were varied; N-terminal conjugates interacted very weakly with the GPCR of interest, whereas C-terminal conjugates bound to the receptor. These chemical biology tools allow interactions of therapeutic proteins:GPCR to be monitored and visualized. The methodology used for site-specific bioconjugation represents an advance in application of 2-pyridinecarboxyaldehydes for N-terminal specific bioconjugations.
Keyphrases
  • cancer therapy
  • photodynamic therapy
  • binding protein
  • protein protein
  • drug delivery
  • drug discovery